Patent · US Active

Compounds and methods for CDK8 modulation and indications therefor

US10703757B2 · kind B2 · utility

3Cited by

72References

38Claims

0Family size

Assignee

Plexxikon Inc. · US

Inventors

Guoxian Wu · Palo Alto, US
Aaron Edward Albers · San Francisco, US
John Buell · San Francisco, US
Elizabeth A. Burton · Berkeley, US
Phuongly Pham · Hayward, US
Hannah Powers · Berkeley, US
Songyuan Shi · Fremont, US
Wayne Spevak · Berkeley, US
Jeffrey Wu · San Francisco, US
Jiazhong Zhang · Foster City, US

Key dates

Filing date	Dec 21, 2017
Grant date	Jul 7, 2020
Priority date	—
Expiry date	Dec 21, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.